A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes.
- DOI
- 10.1016/j.clml.2026.08.017
- Published
- 2026 Aug 31
- Container
- Clinical lymphoma, myeloma & leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clml.2026.08.017,
title = {A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes.},
author = {Chen Y and Cui Q and Qian J and Bai X and Xing R and Liu J and Liu Q and Wu Y and Lai W and Han H and Liu Y and Sun X and Fu L},
year = {2026},
journal = {Clinical lymphoma, myeloma \& leukemia},
doi = {10.1016/j.clml.2026.08.017},
url = {https://doi.org/10.1016/j.clml.2026.08.017}
}RIS
TY - JOUR TI - A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes. AU - Chen Y AU - Cui Q AU - Qian J AU - Bai X AU - Xing R AU - Liu J AU - Liu Q AU - Wu Y AU - Lai W AU - Han H AU - Liu Y AU - Sun X AU - Fu L PY - 2026 JO - Clinical lymphoma, myeloma & leukemia DO - 10.1016/j.clml.2026.08.017 UR - https://doi.org/10.1016/j.clml.2026.08.017 ER -
APA
Y, C., Q, C., J, Q., X, B., R, X., J, L., Q, L., Y, W., W, L., H, H., Y, L., X, S., & L, F. (2026). A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes.. Clinical lymphoma, myeloma & leukemia. https://doi.org/10.1016/j.clml.2026.08.017
Source records
- pubmed · retrieved 2026-09-25T11:41:29.263Z